Elo Life
Elo Life Systems | The Next Generation Ingredient Company
United States · $45.0M raised
- Business Model
- B2B
- Website
- elolife.com
- Total Funding
- $45.0M
- Last Round
- $20.5M Series AJan 2024
- Rounds
- 2
About
Elo Life Systems uses gene editing to develop next-generation food ingredients that improve health and taste for everyday consumers.
Summary
Elo Life is a Biotech company based in United States. It has raised $45.0M in total across 2 rounds, most recently a $20.5M Series A round in Jan 2024. Investors include DCVC (Data Collab), Accelr8 and Novo Holdings A/S.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.